Real-world utilization of andexanet alfa

Am J Emerg Med. 2020 Apr;38(4):827. doi: 10.1016/j.ajem.2020.01.040. Epub 2020 Jan 23.

Authors

Caroline Bernard¹, Eric Villeneuve², Madeleine Genest², Sophie Gosselin³

Affiliations

¹ Faculty of Pharmacy, Université de Montréal, Montreal, Canada; Department of Pharmacy, McGill University Health Centre, Montreal, Canada. Electronic address: caroline.bernard@muhc.mcgill.ca.
² Department of Pharmacy, McGill University Health Centre, Montreal, Canada.
³ Department of Emergency Medicine, McGill University, Montreal, Canada; Department of Emergency Medicine, CISSS Montérégie-Centre, Greenfield Park, Canada.

PMID: 32014372
DOI: 10.1016/j.ajem.2020.01.040

No abstract available

Publication types

Letter
Comment

MeSH terms

Factor Xa Inhibitors*
Factor Xa*
Recombinant Proteins

Substances

Factor Xa Inhibitors
PRT064445
Recombinant Proteins
Factor Xa